Rosana Kapeller-Libermann
Fortune : 384 374 $ au 31/07/2026
Fortune : 384 374 $ au 31/07/2026
Rosana Kapeller-Libermann was the founder of Rein Therapeutics, Inc., founded in 2001, where the title held was Vice President-Research from 2001 to 2009.
Dr. Kapeller-Libermann is the founder of Rome Therapeutics, Inc., founded in 2019, holding the titles of President, Chief Executive Officer & Director since 2019.
Current jobs include Independent Director at Schrödinger, Inc. since 2019 and Independent Director at Cedilla Therapeutics, Inc. since 2018.
Former jobs include Director at Millennium Pharmaceuticals, Inc., Chief Scientific Officer at Nimbus Therapeutics LLC from 2011 to 2018, and Associate Venture Partner at Apple Tree Venture Management LLC.
Education history includes a doctorate from Tufts University conferred in 1994, a doctorate from the University of Campinas conferred in 1986, and a doctorate from Universidade Estadual do Rio de Janeiro.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCHRODINGER, INC. 0,04% | 22/06/2026 | 25 388 ( 0,04% ) | 384 374 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SCHRÖDINGER, INC. | Directeur/Membre du Conseil | 23/01/2019 |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Directeur/Membre du Conseil | 10/07/2018 |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Fondateur | 01/04/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Directeur Technique/Scientifique/R&D | 08/03/2018 |
| REIN THERAPEUTICS INC. | Fondateur | 01/01/2009 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Directeur/Membre du Conseil | - |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Rein Therapeutics, Inc.
Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Campinas
University of Campinas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidade Estadual do Rio de Janeiro
Universidade Estadual do Rio de Janeiro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schrödinger, Inc.
Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for cancer and autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national